These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15689166)

  • 41. L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.
    Di Stefano A; Sozio P; Cocco A; Iannitelli A; Santucci E; Costa M; Pecci L; Nasuti C; Cantalamessa F; Pinnen F
    J Med Chem; 2006 Feb; 49(4):1486-93. PubMed ID: 16480285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total Synthesis of Hinduchelins A-D, Stereochemical Revision of Hinduchelin A, and Biological Evaluation of Natural and Unnatural Analogues.
    Childress ES; Garrison AT; Sheldon JR; Skaar EP; Lindsley CW
    J Org Chem; 2019 May; 84(10):6459-6464. PubMed ID: 31039303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents.
    Schwert DD; Richardson N; Ji G; Radüchel B; Ebert W; Heffner PE; Keck R; Davies JA
    J Med Chem; 2005 Nov; 48(23):7482-5. PubMed ID: 16279808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
    Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An investigation of desferrithiocin metabolism.
    Bergeron RJ; Wollenweber M; Wiegand J
    J Med Chem; 1994 Sep; 37(18):2889-95. PubMed ID: 8071936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2008 Jan; 51(2):331-44. PubMed ID: 18159922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disorders.
    Barton JC
    IDrugs; 2007 Apr; 10(4):270-81. PubMed ID: 17390251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
    Longueville A; Crichton RR
    Biochem Pharmacol; 1986 Nov; 35(21):3669-78. PubMed ID: 3778498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
    J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B.
    Zhao GR; Zhang HM; Ye TX; Xiang ZJ; Yuan YJ; Guo ZX; Zhao LB
    Food Chem Toxicol; 2008 Jan; 46(1):73-81. PubMed ID: 17719161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
    Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
    J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prodrug and covalent linker strategies for the solubilization of dual-action antioxidants/iron chelators.
    Bebbington D; Dawson CE; Gaur S; Spencer J
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3297-300. PubMed ID: 12392736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug evaluation: Deferitrin for iron overload disorders.
    Barton JC
    IDrugs; 2007 Jul; 10(7):480-90. PubMed ID: 17642018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
    Richardson DR; Sharpe PC; Lovejoy DB; Senaratne D; Kalinowski DS; Islam M; Bernhardt PV
    J Med Chem; 2006 Nov; 49(22):6510-21. PubMed ID: 17064069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.
    Liu ZD; Liu DY; Lu SL; Hider RC
    Arzneimittelforschung; 2000 May; 50(5):461-70. PubMed ID: 10858874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of the iron-clearing properties of parabactin and desferrioxamine.
    Bergeron R; Streiff RR; King W; Daniels RD; Wiegand J
    Blood; 1993 Oct; 82(8):2552-7. PubMed ID: 8400302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatic synthesis of catechol and hydroxyl-carboxic acid functionalized chitosan microspheres for iron overload therapy.
    Brzonova I; Steiner W; Zankel A; Nyanhongo GS; Guebitz GM
    Eur J Pharm Biopharm; 2011 Oct; 79(2):294-303. PubMed ID: 21575720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitroaryl-1,4-dihydropyridines as antioxidants against rat liver microsomes oxidation induced by iron/ascorbate, nitrofurantoin and naphthalene.
    Letelier ME; Entrala P; López-Alarcón C; González-Lira V; Molina-Berríos A; Cortés-Troncoso J; Jara-Sandoval J; Santander P; Núñez-Vergara L
    Toxicol In Vitro; 2007 Dec; 21(8):1610-8. PubMed ID: 17669617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deferitazole, a new orally active iron chelator.
    Hider RC; Kong X; Abbate V; Harland R; Conlon K; Luker T
    Dalton Trans; 2015 Mar; 44(11):5197-204. PubMed ID: 25687725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.